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Orofacial granulomatosis (OFG) is a rare inflammatory 
disorder characterised by oral lesions such as lip/facial 
swelling, angular cheilitis, cobblestone phenomenon, 
tag formation, full thickness gingivitis and ulceration 
(1). OFG has been associated with systemic diseases 
such as Crohn’s disease (CD) (2) and with food hyper-
sensitivity reactions(3-5).
Abstract
Objectives: The aim of this investigation was to characterise and compare the inflammatory infiltrates in patients 
with orofacial granulomatosis solely (OFG-S) and OFG with coexisting Crohn’s disease (OFG+CD). 
Study Design: Biopsy specimens with granulomas were obtained from patients with OFG-S (n=11) and OFG+CD 
(n=11) and immunostained with antibodies against CD1a, CD3, CD4, CD8, CD11c, CD20, CD68 and mast cell 
tryptase, followed by quantitative analysis. 
Results: Analyses of the connective tissue revealed a significantly higher number of CD3�expressing T cells 
and CD11c-expressing dendritic cells in the connective tissue of patients with OFG-S compared to patients with 
OFG+CD� Mast cells displayed a high level of activation, although no significant difference was detected when 
comparing the two groups. 
Conclusions: The results show a different composition of the inflammatory infiltrate in patients with OFG�S com-
pared to patients with OFG+CD� The present observations support that partlydivergent immune mechanisms are 
involved in these two different subcategories of OFG.
Key words: Granulomas, autoimmunity, T cells, B cells, dendritic cells, children, adults.
Current knowledge implicates a complex involvement 
of different types of immune cells in patients with OFG 
and CD, and T cells have been attributed a major role in 
the pathogenesis of these two disorders (6,7). Dendritic 
cells (DCs) influence the fate decisions of naive CD4�
expressing T cells towards Th1, Th2 or Th17 subsets at 
the early stages of activation (8,9)� Two major subsets 
of DCs reside in the oral mucosa, CD1a�positive Lang-
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erhans cells (LCs) and CD11c�positive lamina propria 
resident DCs (10)� However, the influence of DCs in the 
pathogenesis of OFG has not been fully elucidated.
In patients with OFG with or without concurrent CD, 
the presence of non-caseating granulomas in tissue 
specimens from affected areas is considered to be a 
hallmark of histopathologically proven diseases (1)� In 
both OFG and CD, granulomas are characterised by the 
presence of multinucleated giant cells of macrophage 
origin (7,11) that express CD68 molecules� The underly-
ing mechanisms of granuloma formation inthe two con-
ditionsare still unknown�
It has been suggested that IgE�expressing B cells in the 
submucosa of OFG patients play an important role in the 
pathogenesis and explain previous findings suggesting a 
link between food allergy and OFG (12)� Mast cells are 
important players in IgE�mediated reactions, including 
food-elicited conditions (13). So far the role of mast cells 
in OFG has not been thoroughly investigated. 
OFG may be considered a separate disease entity when 
appearing exclusively in the oral region. When it exists 
in conjunction with a systemic disease, it may repre-
sent a distinct subcategory. Immune mechanisms and 
the reflecting immunohistochemistry may partly dif-
fer between these subcategories� Therefore, the aim of 
this investigation was to characterise and compare the 
immune cell infiltration in two groups of patients with 
OFG, one without systemic diseases (OFG-S) and the 
other one with coexisting CD (OFG+CD). 
Patient and Methods
-Patients and samples
A total of 22 OFG patients (OFG�S [n=11] and OFG+CD 
[n=11]) with a median age of 16 years (range 8–51 years) 
were included (Table 1)� The clinical inclusion criteria 
for OFG in both groups were lip and/or facial swelling 
together with tag formation, cobblestone phenomenon 
and/or angular cheilitis� The diagnosis of paediatric and 
adult CD was confirmed according to established criteria 
(14,15). In case of gastrointestinal symptoms, the patients 
were subjected to gastrointestinal endoscopy with spe-
cial focus on CD. No sarcoidosis or proven food-induced 
OFG were found in any of the patients� Two patients in 
the OFG+CD group received mesalazine (PentasaTM, 
Ferring, Saint-Prex, Switzerland) and all the other pa-
tients were free from medication� Extended�release me-
salamine granules are known to have a local effect in the 
gut mucosa (16)� The histopathological inclusion criterion 
was the presence of non-caseating granulomas in at least 
one biopsy at any location of the oral mucosa (Table 1)� 
In this retrospective study, biopsies were taken from the 
most prominent OFG manifestation site: gingivae (n=8), 
bucca (n=7), sulcus (n=7) and the lip (n=5).
-Immunohistochemistry
Antibodies: Anti�human CD1a (clone 010, isotype 









1 OFG-S M 18 Gingiva 
2 OFG-S M 18 Sulcus 
3 OFG-S M 8 Lip, bucca, gingiva 
4 OFG-S M 13 Lip, sulcus, gingiva 
5 OFG-S M 18 Sulcus 
6 OFG-S M 17 Lip 
7 OFG-S M 15 Lip 
8 OFG-S F 18 Sulcus 
9 OFG-S M 18 Bucca, lip 
10 OFG-S F 15 Sulcus 
11 OFG-S M 22 Gingiva 
12 OFG+CD F 25 Sulcus 
13 OFG+CD M 13 Bucca 
14 OFG+CD M 15 Gingiva 
15 OFG+CD M 15 Bucca 
16 OFG+CD M 51 Bucca 
17 OFG+CD M 15 Gingiva 
18 OFG+CD M 14 Bucca 
19 OFG+CD M 17 Gingiva 
20 OFG+CD M 10 Bucca 
21 OFG+CD M 13 Gingiva 
22 OFG+CD F 24 Sulcus 
?
Table 1. Patient characteristics. 
OFG-S: Orofacial granulomatosis solely; OFG+CD: Orofacial granu-
lomatosis with Crohn’s disease.
IgG1, kappa), CD20 (clone L26, isotype IgG2a, kappa), 
mouse-monoclonal primary antibody anti-CD68, (clone 
KP1, isotype IgG1, kappa) and mast cell tryptase (MCT; 
clone AA1, isotype IgG1, kappa) were purchased at 
Dako Sweden AB� Monoclonal mouse antibodies anti�
human CD3 (clone F7�2�38, isotype IgG1, kappa) and 
monoclonal rabbit CD11c (clone EP1347Y, isotypeIgG) 
was obtained from AbCam, Cambridge, United King-
dom� Monoclonal antibody CD4 (clone 4B12, NCL�
CD4-368) and monoclonal antibody CD8 (clone 4B11, 
NCL�CD8�4B11) were purchased at Novocastra, Leica 
Microsystems AB, Sweden�
Immunostaining: Paraffin�embedded tissue specimens 
were cut at 4 µm thick sections and mounted on Da-
koIHC microscope slides, deparaffinised and then re�
dehydrated� Endogenous peroxidase was blocked with 
3% hydrogen peroxide for 5 min, washed in buffer (0.1% 
phosphate buffered saline (PBS) + Triton�X�100 0�05%) 
for 5 min and followed by block non�specific proteins 
with 10% normal serum in 0.5% PBS for 20 min. For 
CD4 antigen retrieval in Tris�EDTA pH 9�0 was done 
in microwave oven for 10 min followed by blocking 
with Background Sniper (Biocare, Concord, CA, USA, 
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BS966M) for 15 min. Staining with primary antibody 
against CD1a, CD3 (dilution 1:100), CD4 (dilution 1:200), 
CD8 (dilution 1:100), CD11c (dilution 1:65), CD20 (dilu-
tion 1:200), CD68 (dilution 1:1000) and mast cell tryptase 
(MCT) (dilution 1:1500) in 1% biotinylated secondary 
antibody (BSA) was performed for 60 min and wash in 
buffer for 2×5 min, followed by an incubation with BSA 
(Vector, Burlingame, CA 94110, USA) for 30 min and 
wash in buffer for 2×5 min. For CD4 Mach3MouseProbe 
(Biocare, M3M532L) was used as secondary antibody� 
Incubation with avidin�biotin complex (Vector ABC: 2�5 
ml PBS + 50 μl A + 50 μl B) for 30 min was performed 
followed by buffer wash for 2×5 min� DAB (DAB: One 
set of Sigma tablets to 5 ml of distilled H2O) was added 
to slides for 2 min followed by washing in distilled H2O 
several times. For CD4 a tertiary step was performed us-
ing Mach3MouseAP�polymer (Biocare, M3M532L) for 
30 min and Vulcan Fast Red substrate (Biocare, FR805S) 
for 2 min with levamisol (Vector, SP�5000)� Background 
staining in Mayer’s hematoxylin was carried out for 40 
seconds followed by blueing in tap water for 4 min. Final-
ly, the sections were dehydrated and mounted with Pertex 
(Histolab Products AB, Spånga, Sweden)� All steps were 
done at room temperature.
Quantitative analysis was performed on a minimum of 
two areas per tissue section with an average of four ar-
eas per patient, apart from one patient where the biopsy 
was too small to count two different sections. Digital-
ised images from one to eight fields, dependent on bi-
opsy size, at a magnification of ×80 were obtained using 
a light microscope (LeitzWetzler, Leica Microsystems, 
Wetzlar, Germany) equipped with a UC30 Olympus 
camera (Olympus Microsystems, Norcross, GA 30071, 
USA)� The sections were then analysed using the com-
puter software BioPixiQ 2.0 (BioPix, Gothenburg, 
Sweden), where the percentage of stained tissue area 
was calculated as previously described (17)� The areas 
of positively stained cells within the connective tissue 
containing granulomas were registered� These areas 
of positive cells were then expressed as a percentage 
of the connective tissue area. In addition to the quanti-
tative analyses of mast cells using this method, analy-
ses of mast cell degranulation were performed with a 
semiquantitative scale where the amount of released 
tryptase-positive granules was assessed: 0: no released 
granules, 1: low number of released granules (1-3), 2: 
moderate number of released granules (4-9) and 3: high 
number (10 or above) of released granules. Mast cell-
specific proteases include tryptases, chymases and car-
boxypeptidase A, but as tryptases are the most abun-
dant of mediators found in granules from mast cells, we 
used tryptase as a marker for mast cells� The number of 
degranulated cells was expressed as a percentage of all 
tryptase-positive cells. For statistical analysis, data in 
scale steps 0 + 1 and 2 + 3 were merged.
-Statistical analyses
Analyses of differences between groups were calcu-
lated by the Mann�Whitney U�test, utilising the statisti-
cal software GraphPad Prism Version 6.0b (GraphPad 
Software, Inc�, San Diego, CA, USA)� A p-value <0.05 
was considered as a significant difference�
This study was approved by the Ethics Committee at 
The Sahlgrenska Academy, University of Gothenburg 
and informed consent was obtained from all patients, 
and when needed, also from their parents.
Results
Immunohistochemical staining of biopsies from the 11 
patients with OFG-S and the 11 patients with OFG+CD 
was performed using markers for CD1a, CD3, CD4, 
CD8, CD11c, CD20, CD68 and MCT� The results of 
CD3, CD11c, CD20 and MCT positively stained cells in 
the connective tissues are displayed in figure 1�
�T�cells 
CD3�positiveT cells were found in the connective tissue 
from both OFG-S and OFG+CD patients in a similar 
distribution pattern and with T cells evenly distributed 
in the connective tissue (Fig� 2A�B) as well as cluster-
ing around the granulomas (Fig� 2A)�There was a sig-
nificantly higher number of CD3�expressing T cells, as 
reflected by positively stained areas, in the connective 
tissues in patients with OFG-S compared to patients 
with OFG+CD (Fig� 1A; p = 0.005).
CD4-expressing cells with lymphocyte morphology 
could be observed both within the granulomas and evenly 
spread out in the connective tissue. In some tissue sections 
CD4-positive cells could also be detected in the epithe-
lium� There was no significant difference in the presence 
of CD4-positive cells between the OFG-S and OFG+CD 
groups. Neither was there any difference in the presence 
of CD8-positive cells between the two groups and similar 
tissue distribution as for CD4-positive cells was observed.
-Dendritic cells and macrophages
In the connective tissue the CD1a�positive Langerhans 
cells (LCs) were evenly distributed, while in the epi-
thelium LCs were observed in clusters and had a more 
prominent dendritic appearance� There was no signifi-
cant difference in the number of LCs in patients with 
OFG-S compared to OFG+CD patients. 
CD11c molecules were mostly expressed by non-dendritic 
multinucleated giant cellspresent in the granulomas (Fig. 
2C)� This marker could also be observed in other parts 
of the connective tissue (Fig. 2D), but then expressed by 
cells with a dendritic morphology. CD11c-positive cells 
were significantly more abundant in the OFG�S group 
compared to the OFG+CD group (Fig. 1B; p=0.007). 
CD68-expressing macrophages were seen distributed in 
the connective tissue including granulomas. Regarding
the number of CD68-expressingcells, there was no sig-
nificant difference between the two groups� 
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Fig. 1. Positively stained area (%) of connective tissue in patients with orofacial granulomatosis 
solely (OFG-S; circles) and orofacial granulomatosis with Crohn s´ Disease (OFG+CD; squares) for 
A) CD3�expressing T cells, B) CD11c-expressing cells, C) CD20-expressing cells and D) tryptase 
(MCT)�expressing mast cells� Median values and interquartile ranges are indicated� ** P < 0.01.
Fig. 2. Immunostaining panel of connective tissue in patients with OFG-S and OFG+CD. CD3 expressing cells in A) OFG-S and B) 
OFG+CD, CD11c expressing cells in C) OFG-S and D) OFG+CD, 
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-B-cells  
The distribution of CD20 molecule�expressing B cells 
varied between biopsies; in some cases a homogene-
ous distribution was noted (Fig� 2E�F), while in other 
cases an accumulation surrounding granulomas was 
observed� No significant difference could be seen re-
garding numbers, although there was a trend towards 
more B cells in the OFG-S group compared to the 
OFG+CD group (p=0.087; Fig. 1C). In general, the 
CD20-expressing cells showed lymphocyte morphol-
ogy, although to some extent with a more irregular ap-
pearance than to be expected by tissue-resident lym-
phocytes (Fig� 3A�B)� 
-Mast cells
Mast cells were found in both the OFG-S and the 
OFG+CD groups and notably showed a high degree of 
mast cell tryptase release in both groups (Fig� 2G�H)� No 
significant difference could be detected when compar-
ing the total frequency of granule-releasing mast cells 
in the OFG-S group with the OFG+CD group (Fig. 1D). 
When looking at levels of granule release, the no gran-
ule group (Fig� 4A) and the low granule group (Fig� 4B) 
were merged, with no significant difference between pa-
tients with OFG�S and OFG+CD (Table 2)� Neither was 
any difference observed between OFG-S and OFG+CD 
(Table 2) when merging the moderate (Fig� 4C) and the 
high number (Fig. 4D) granule groups. 
�Epitheloid cell granulomas
According to the inclusion criteria, all biopsies from 
the 22 OFG patients showed granuloma formation with 
multinucleated giant cells and lymphocytes observed by 
routine hematoxylin-eosine histology. Immunostaining 
showed that the multinucleated giant cells expressed 
CD68, the marker for macrophages� In both groups, 
approximately 10% of the area in the connective tissue 
represented granulomas. 
Discussion
In this study we compared various cell populations in 
oral lesions of patients with OFG solely (OFG-S) and 
OFG with concomitant CD (OFG+CD)� T cells were 
present in higher numbers in lesions from patients with 
OFG-S compared to patients with OFG+CD.Further-
more, lesions from patients with OFG-S had higher 
numbers of CD11c-expressing dendritic cells than those 
in patients with OFG+CD� These observations support 
the view that these two subcategories of OFG have im-
munopathogenic differences.
Fig. 2. CD20 expressing cells in E) OFG-S and F) OFG+CD� MCT�expressing cells in G) OFG-S and H) OFG+CD. 
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Fig. 4. Immunostainings of tryptase positive granule-releasing mast cells.Mast cell with 
A) no degranulation (0 granules), B) low number of granules (1-3), C) moderate number of 
granules (4-9) and D) high number of relase of granules (10 or above)� Magnification ×400�
Fig. 3. CD20- expressing B cells (arrows) with A) lymphocytic morphology and B) with a more irregular morphology� Magnification 
x400. 
Both OFG (1) and CD (18) belong to the group of granu-
lomatous diseases, characterised by the presence of 
non-caseating granulomas consisting of multinucleated 
giant cells expressing CD68 molecules (7,11)� Although 
granuloma is not a prerequisite for the diagnosis of 
OFG, it strengthens the present study in that only OFG 
patients with granuloma in their oral biopsies were in-
cluded� This provides greater diagnostic accuracy and 
probably also more uniform and representative observa-
tions of the OFG inflammation� 
We show that CD3�positive T cells are present in higher 
amounts in tissue specimens from patients with OFG-S 
than those in patients with OFG+CD. Regarding OFG-S, 
this is well in line with the results presented by Freys-
dottir and co�workers, who observed T cells both in and 
















Table 2. Semiquantification of granulation release by mast cells in 
% of all mast cells.
Gradings: 0: no granules, 1: low number of granules (1-3 granules), 2: 
moderate  number(4-9 granules) 3: high  number (10 granules or above).
Med Oral Patol Oral Cir Bucal. 2014 Nov 1;19 (6):e584-91.                                                                                                                                          Immunophenotype in orofacial granulomatosis
e590
(7)� Despite a significant difference in the percentage of 
CD3�positive Tcells between the two patient groups, we 
were not able to find any differences in the percentages 
of the subsets of CD4-positive or CD8-positivecells.
This may be due to interference from CD4 molecule-
sexpressed by DCs, granulocytes and macrophages, 
making a valid comparison difficult (19,20)�
Two major subsets of DCs reside in oral mucosa, CD1a�
positive Langerhans cells (LCs) and CD11c�positive 
lamina propria resident DCs(10). Both these antigen-
presenting cells may be of importance in disease pa-
thology. In this study the presence of CD1a-expressing 
LCs in connective tissue from OFG�S and OFG+CD 
patients did not differ� However, our impression is that 
the number of CD1a-expressing cells is increased in 
comparison to healthy oral connective tissue� This is 
in line with our previous studies showing higher num-
bers of CD1a�expressing LCs in connective tissue of 
other oral inflammatory disorders (lichen planus and 
graft-versus-host disease) compared to healthy oral 
mucosa (21,22).
Granulomas are considered to be sites of persistent anti-
gen localisation (23), where the immune system tries to 
eliminate deleterious antigens (24). In a recent experi-
mental study of mycobacterial granulomas, DCs were 
found to traffic in and out of granulomas (25), indicating 
a central role for this cell subset in disease pathogenesis. 
We observed that CD11c-positive DCs were present in 
the lamina propria of the OFG-S patients in higher num-
bers than in patients with OFG+CD, which may indi-
cate that DCs participate differently in the pathogenesis 
of OFG�S compared to OFG+CD� The influx of DCs in 
OFG�S patients may be a reflection of an oral reaction 
pattern involving an exposure to exogenous antigens 
such as food constituents or bacterial components. Spe-
cific food constituents have been attributed a trigger-
ing role in OFG (3,26,27), and a continuous exposure to 
food antigens may in a sensitised individual lead to the 
recruitment of DCs to oral tissues.
B cells have previously been found in OFG (12) and here 
we show that CD20-expressing B cells are found in the 
connective tissue with a heterogeneous distribution. 
Thus, tissue lesions from patients with OFG�S seem to 
recruit more antigen�presenting cells, more T cells and 
a trend towards more B-cells than disease affected tis-
sues from patients with OFG+CD. 
Importantly, a Th2�skewed T cell response regulates 
B cell class switching to IgE and mast cell activation 
(28)� The occurrence of B cell class switching to IgE has 
been reported in OFG (12)� Our findings show a great 
number of mast cells with released granules that may 
be the result of IgE�mediated mast cell activation� In 
both the OFG-S and OFG+CD groups, high mast cell 
activity was registered, although no significant differ-
ence between the two groups was recorded. Increased 
frequencies of mast cells have also been reported in 
gut mucosa from patients with CD, and these cells have 
been implicated in the pathogenesis of this disease (13). 
Food antigens as a triggering factor may be considered, 
but other exogenous stimuli may also be of importance. 
In a recent paper, Nakamura et al. provided evidence for 
Staphylococcus delta-toxin causing mast cell degranu-
lation in patients with atopic dermatitis (29). In OFG 
a similar microbial-induced reaction might be of rel-
evance, especially for the perioral and lip lesions� Thus, 
the high mast cell activity in both OFG-S and OFG-CD 
may be an important finding with clinical implications� 
OFG-S and OFG-CD patients investigated in this study 
display a skewed gender distribution with a predomi-
nance of males� This is in accordance with our recently 
published Swedish cohort study, where the male:female 
ratio was approximately 3:1 (30). Furthermore, in a 
study from Sweden on pediatric patients with CD, male 
patients dominated (31). In contrast, studies from other 
geographic areas report a more homogenous gender dis-
tribution of OFG with and without CD (12,32,33) with 
male:female ratios of approximately 1:1. 
OFG-S and OFG+CD may represent two subcategories that 
could differ in various aspects, such as immune mecha-
nisms, clinical characteristics and genetics� As an example, 
Savage and co�workers found that serum IgA antibodies to 
S� cerevisiae were raised significantly in the OFG+CD but 
not in the OFG-S group (34). Regarding clinical charac-
teristics, we have recently observed that OFG-S patients 
perceived their overall discomfort, aesthetic problems and 
social discomfort as more severe than OFG+CD patients. 
Furthermore, the two groups seemed to differ regarding 
genetic characteristics, that is, NOD2 gene variation pat-
tern (30). In conclusion, the present study reinforces the 
concept of OFG as a heterogeneous clinical entity.
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